Millennium Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
Millennium Management's HRTX Position: Q3 2026 in Review
Millennium Management reduced its Heron Therapeutics (HRTX) stake by 64% in Q3 2026, selling an estimated $989K and leaving 1,459,918 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #5085.
Millennium Management first reported a position in HRTX in Q1 2014 and has held it in 41 quarters since. The position peaked at $23.7M in Q2 2015. 159 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.
- Millennium Management held 1,459,918 shares of Heron Therapeutics worth $458K as of Q3 2026.
- Millennium Management sold 2,610,183 Heron Therapeutics shares in Q3 2026, an estimated $989K.
- Heron Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5085 holding.
- Millennium Management first reported a position in Heron Therapeutics in Q1 2014 and has held it in 41 quarters since.
- Millennium Management's Heron Therapeutics position peaked at $23.7M in Q2 2015.
- 159 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.